Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline

Banaschewski, Tobias and Coghill, David and Santosh, Paramala and Zuddas, Alessandro and Asherson, Philip and Buitelaar, Jan and Danckaerts, Marina and Döpfner, Manfred and Faraone, Stephen V. and Rothenberger, Aribert and Sergeant, Joseph and Steinhausen, Hans-Christoph and Sonuga-Barke, Edmund J. S. and Taylor, Eric. (2006) Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline. European Child and Adolescent Psychiatry, 15 (8). pp. 476-495.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A5838907

Downloads: Statistics Overview


A systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorder is reported, giving effect sizes and numbers-to-treat for extended-release stimulant preparations and atomoxetine (ATX). A panel of experts from several European countries used the review to make recommendations about the use of these drugs in practice, and conclusions are reported: (1) Long-acting preparations should be available and used; (2) They should not replace short-acting drugs (which will be the initial treatment for many children for reasons of cost and flexibility of dosing). Individual clinical choice is needed. (3) Both ATX and extended-release preparations of stimulants should be available. The choice will depend upon the circumstances, and detailed recommendations are made.
Faculties and Departments:07 Faculty of Psychology > Departement Psychologie > Ehemalige Einheiten Psychologie > Clinical Child and Adolescent Psychology (Schneider)
UniBasel Contributors:Steinhausen, Hans-Christoph
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:27 Nov 2017 13:03
Deposited On:08 Jun 2012 06:44

Repository Staff Only: item control page